REJUVEL BIO-SCIENCES, INC. (CIK: 0001481427) EDGAR, Information, Filings... CompaniesBIO.Com

REJUVEL BIO-SCIENCES, INC.

Mailing address
15800 PINES BLVD., SUITE 3116, PEMBROKE PINES, Florida, 33027
Phone
(800) 670-0448
State location
Florida
State of incorporation
Florida
Fiscal year end
December 31
SIC
5190 - (CF Office: Office of Trade & Services) WHOLESALE-MISCELLANEOUS NONDURABLE GOODS
Filings
N/A

REJUVEL BIO-SCIENCES, INC. (CIK: 0001481427) is an American company incorporated in the state of Florida. Head office is located at 15800 PINES BLVD., SUITE 3116, PEMBROKE PINES, Florida, 33027. Work in the industry 5190 - (CF Office: Office of Trade & Services) WHOLESALE-MISCELLANEOUS NONDURABLE GOODS. REJUVEL BIO-SCIENCES, INC. is a public company and trade via Over-The-Counter (OTC).

Old names:

Technology Applications International Corp from 2011-18-Apr to 2015-11-Jun
Raj Ventures, Inc. from 2010-19-Jan to 2011-28-Mar

Owner	Filings	Transaction Date	Type of Owner
PAVLIK JOSEPH	0001706566	Jan-19-2017	director, officer: CEO
STICKLER JOHN	0001612799	May-20-2014	director
SCIMECA CHARLES J	0001081980	Apr-12-2010	director, 10 percent owner, officer: President, Secretary,Treasurer
Foyo Colleen	0001428209	Mar-19-2010	director, 10 percent owner, officer: President Secretary Treasurer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by REJUVEL BIO-SCIENCES, INC.

Filings	Format	Description	Filed/Effective	File/Film Number
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001469709-17-000257 (34 Act) Size: 7 KB	Oct-11-2017	000-53878 171132553
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001469709-17-000123 (34 Act) Size: 40 KB	Jun-08-2017	005-85414 17900559
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001469709-17-000122 ( Act) Size: 4 KB	Jun-08-2017
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001469709-17-000121 (34 Act) Size: 39 KB	Jun-08-2017	005-85414 17900513
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001469709-17-000120 ( Act) Size: 4 KB	Jun-08-2017
8-K	Document	Current report filing Acc-no: 0001469709-17-000027 (34 Act) Size: 15 KB	Feb-28-2017	000-53878 17647015
8-K	Document	Current report filing Acc-no: 0001469709-16-000942 (34 Act) Size: 12 KB	Nov-10-2016	000-53878 161988249
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001469709-16-000940 ( Act) Size: 7 KB	Nov-09-2016
8-K	Document	Current report filing Acc-no: 0001469709-16-000936 (34 Act) Size: 4763 KB	Oct-27-2016	000-53878 161954757
8-K	Document	Current report filing Acc-no: 0001469709-16-000847 (34 Act) Size: 9 KB	Jun-02-2016	000-53878 161693175
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001469709-16-000801 ( Act) Size: 4 KB	May-12-2016
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001469709-16-000740 (34 Act) Size: 12 KB	Mar-30-2016	000-53878 161540810
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001469709-16-000714 ( Act) Size: 6 KB	Mar-11-2016
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001469709-16-000670 ( Act) Size: 4 KB	Jan-28-2016
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001140361-16-047799 (34 Act) Size: 97 KB	Jan-14-2016	005-85414 161342574
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001469709-15-000607 (34 Act) Size: 1927 KB	Nov-16-2015	000-53878 151235893
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001469709-15-000485 (34 Act) Size: 5064 KB	Aug-19-2015	000-53878 151062778
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001469709-15-000482 (34 Act) Size: 41 KB	Aug-19-2015	005-85414 151062756
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001469709-15-000481 (34 Act) Size: 40 KB	Aug-19-2015	005-85414 151062754
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001469709-15-000466 (34 Act) Size: 12 KB	Aug-14-2015	000-53878 151055186

Recent 20 filings. View all REJUVEL BIO-SCIENCES, INC. filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

REJUVEL BIO-SCIENCES, INC. overview
REJUVEL BIO-SCIENCES, INC. job
REJUVEL BIO-SCIENCES, INC. stock
REJUVEL BIO-SCIENCES, INC. ownership
REJUVEL BIO-SCIENCES, INC. CEO
REJUVEL BIO-SCIENCES, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.